You are here: Industry Insights > AstraZeneca

News List

AstraZeneca’s COVID-19 vaccine data may fall short of desirable protection results: GlobalData expresspharma
August 26, 2020
The ongoing early study only requires 30 COVID-19 cases to detect vaccine efficacy, which is much too small to be sure of protection and would only be suitable to support other larger trials, it states.
Catalent and AstraZeneca Enter Vaccine Manufacturing Deal contractpharma
August 25, 2020
Catalent Inc. will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19 vaccine, AZD1222, at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland.
AZ partners with RenalytixAI in chronic disease pact pharmatimes
August 24, 2020
AstraZeneca has linked with RenalytixAI to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases.
Australia signs deal for AstraZeneca’s Covid-19 vaccine pharmaceutical-technology
August 20, 2020
The Australian Government has signed an agreement with AstraZeneca for the supply of the company’s Covid-19 vaccine candidate developed by the University of Oxford.
AstraZeneca gets DCGI nod to import and market Olaparib film coated tablets expresspharma
August 20, 2020
It is additionally indicated as a monotherapy to treat adults with metastatic castration-resistant prostate cancer and homologous recombination repair gene mutations。
Priority review for Imfinzi's less-frequent dosing regimen pharmatimes
August 19, 2020
AstraZeneca's Imfinzi (durvalumab) has been granted a priority review in the US for a new four-week, fixed-dose regimen for treatment of non-small cell lung cancer (NSCLC) and bladder cancer.
AstraZeneca Concludes Agreement with EC for COVID-19 Vaccine americanpharmaceuticalreview
August 19, 2020
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine.
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine worldpharmanews
August 17, 2020
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine.
AstraZeneca ships first doses of flu vaccine pharmatimes
August 17, 2020
AstraZeneca has announced the first shipment of Flumist Quadrivalent vaccine doses have been sent to the US for the upcoming influenza season.
Argentina and Mexico to make AstraZeneca COVID-19 vaccine for Latin America expresspharma
August 14, 2020
The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the vaccine for all of Latin America except Brazil.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page